Recent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment

Authors

  • M. Valerie Lin M.D.,

  • Raymond Chung M.D.


  • From the Gastrointestinal Unit, Liver Center and Gastroenterology Division, Massachusetts General Hospital, Boston, MA.

  • Potential conflict of interest: Nothing to report.

Raymond T. Chung, Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Blake 4, Boston, MA 02114. E-mail: rtchung@partners.org.

Abstract

Watch a video presentation of this article

Answer questions and earn CME

Ancillary